Heart Failure and Sudden Cardiac Death Japan Registry (HINODE)
Heart Failure Indication and Sudden Cardiac Death Prevention Trial Japan
Sponsor: Boston Scientific Corporation
This observational or N/A phase trial investigates Arrhythmias, Cardiac and Heart Failure and is currently completed. Boston Scientific Corporation leads this study, which shows 19 recorded versions since 2017 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
19 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Mar 2022 — Jul 2024 [monthly]
Completed
-
Sep 2021 — Mar 2022 [monthly]
Completed
▶ Show 14 earlier versions
-
Feb 2021 — Sep 2021 [monthly]
Completed
-
Jan 2021 — Feb 2021 [monthly]
Completed
-
Dec 2020 — Jan 2021 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
May 2020 — Dec 2020 [monthly]
Active Not Recruiting
-
Feb 2020 — May 2020 [monthly]
Active Not Recruiting
-
Sep 2019 — Feb 2020 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Apr 2019 — Sep 2019 [monthly]
Recruiting
-
Feb 2019 — Apr 2019 [monthly]
Recruiting
-
Oct 2018 — Feb 2019 [monthly]
Recruiting
-
Sep 2018 — Oct 2018 [monthly]
Recruiting
-
Jun 2018 — Sep 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jul 2017 — Aug 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Boston Scientific Corporation
- ICON Clinical Research
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Amagasaki, Japan , Bunkyo, Japan , Bunkyō, Japan , Chūō, Japan , Fukuoka, Japan , Himeji, Japan , Hitachi, Japan , Ichinomiya, Japan , Kasuga, Japan , Kawasaki, Japan and 16 more locations